| 000 | 01775 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514211717.0 | ||
| 264 | 0 | _c20050111 | |
| 008 | 200501s 0 0 eng d | ||
| 022 | _a0013-9580 | ||
| 024 | 7 |
_a10.1111/j.0013-9580.2004.32404_1.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPanayiotopoulos, Chrystostomos P | |
| 245 | 0 | 0 |
_aEfficacy and tolerability of the new antiepileptic drugs: commentary on the recently published practice parameters. _h[electronic resource] |
| 260 |
_bEpilepsia _cDec 2004 |
||
| 300 |
_a1646-9; author reply 1649-51 p. _bdigital |
||
| 500 | _aPublication Type: Letter | ||
| 650 | 0 | 4 |
_aAnticonvulsants _xadverse effects |
| 650 | 0 | 4 |
_aClinical Trials as Topic _xstandards |
| 650 | 0 | 4 |
_aEpilepsy _xclassification |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPractice Guidelines as Topic _xstandards |
| 650 | 0 | 4 | _aTerminology as Topic |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aBenbadis, Selim R | |
| 700 | 1 | _aCovanis, Anthanasios | |
| 700 | 1 | _aDulac, Olivier | |
| 700 | 1 | _aDuncan, John S | |
| 700 | 1 | _aEeg-Olofsson, Orvar | |
| 700 | 1 | _aFerrie, Colin D | |
| 700 | 1 | _aGrünewald, Richard A | |
| 700 | 1 | _aKasteleijn-Nolst Trenite, Dorothee G A | |
| 700 | 1 | _aKoutroumanidis, Michael | |
| 700 | 1 | _aMartinovic, Zarko | |
| 700 | 1 | _aNewton, Richard W | |
| 700 | 1 | _aParker, Alasdair P | |
| 700 | 1 | _aSalas-Puig, Janvier | |
| 700 | 1 | _aSander, J W A S | |
| 700 | 1 | _aShorvon, Simon | |
| 700 | 1 | _aWatanabe, Kazuyoshi | |
| 700 | 1 | _aWhitehouse, William P | |
| 700 | 1 | _aYouroukos, Sotirios | |
| 773 | 0 |
_tEpilepsia _gvol. 45 _gno. 12 _gp. 1646-9; author reply 1649-51 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.0013-9580.2004.32404_1.x _zAvailable from publisher's website |
| 999 |
_c15256909 _d15256909 |
||